Cargando…
Correlation between β-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma
Aberrant Wnt-signaling caused by mutants of β-catenin, a key regulator of the canonical Wnt-signaling pathway, is frequently detected in cancer. Only recently, it was suggested that in hepatocellular carcinoma (HCC) the expression of the target gene glutamine synthetase (GS) is a highly reliable mar...
Autores principales: | Austinat, Madeleine, Dunsch, Ruediger, Wittekind, Christian, Tannapfel, Andrea, Gebhardt, Rolf, Gaunitz, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2287186/ https://www.ncbi.nlm.nih.gov/pubmed/18282277 http://dx.doi.org/10.1186/1476-4598-7-21 |
Ejemplares similares
-
4-Aminoethylamino-emodin – a novel potent inhibitor of GSK-3β– acts as an insulin-sensitizer avoiding downstream effects of activated β-catenin
por: Gebhardt, Rolf, et al.
Publicado: (2010) -
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Kaiting, et al.
Publicado: (2022) -
Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
por: Khalaf, Ahmed M, et al.
Publicado: (2018) -
Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide
por: Fako, Valerie, et al.
Publicado: (2016) -
Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
por: Aoki, Tomoko, et al.
Publicado: (2022)